Prophylaxis News and Research

RSS

Recent innovations in infectious disease diagnostics

A recent Clinical Biochemistry editorial reports the latest innovations in the field of infectious disease diagnostics.

17 Oct 2022

Did the risk of severe COVID-19 in the immunodeficient population of the UK change following vaccination deployment?

Researchers evaluated the changing risk of severe COVID-19 outcomes in individuals with primary and secondary immunodeficiencies in the context of COVID-19 vaccinations.

17 Oct 2022

Inhalation therapeutics against COVID-19

A recent study published in the Pulmonary Pharmacology & Therapeutics journal described different inhalation therapeutic agents for treating respiratory viral infections like coronavirus disease 2019 (COVID-19).

17 Oct 2022

Amplification of venous thromboembolism risk by COVID-19 among malignancy patients

In a new study, researchers reported the mechanisms involved in COVID-19 coagulopathy and the significance of SARS-CoV-2 infections for cancer patients concerning outcomes, thromboembolic complication risks, and consequences of management strategies.

14 Oct 2022

Yeast display used to generate SARS-CoV-2 RBD-specific nanobodies

Researchers engineered biparatopic nanobodies against SARS-CoV-2.

5 Oct 2022

Study finds the majority of post-vaccination monkeypox infections occur within 2 weeks of receiving the first dose of MVA-BN

Researchers described the human monkeypox virus infection after vaccination with the modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine.

5 Oct 2022

Preventive malaria treatment is a cost-effective strategy for saving young lives

Young children in sub-Saharan Africa often become severely anaemic as consequence of a malaria infection. Treating them requires blood transfusions and they must stay hospitalized for several days.

3 Oct 2022

French study reports growing evidence of sexual activity-linked transmission of monkeypox

In a new study, researchers described patients with monkeypox virus (MPXV) infection.

3 Oct 2022

What is the efficacy of curcumin as a photosensitizer, prophylactic and therapeutic agent against SARS-CoV-2?

In a new study, researchers investigated the efficacy of curcumin as a blue light photosensitizing agent for photodynamic therapy (PDT), as a prophylactic agent, and as a therapeutic agent against SARS-CoV-2.

30 Sep 2022

Designing a new treatment to treat migraine effectively

In this interview, we speak to Mudra Kapoor, Vice President of Global Medical Affairs for Neuroscience at AbbVie, about atogepant, their new treatment option for migraine.

From AbbVie 26 Sep 2022

How smallpox and monkeypox viruses affect the nervous system

A recent study provides an overview of existing literature on the complications of infection with both smallpox and monkeypox virus.

25 Sep 2022

Generating a mutation in key molecules could offer new way to prevent and treat gonorrhea

Creating a mutation that inhibits how the bacterial pathogen Neisseria gonorrhoeae causes gonorrhea, a common sexually transmitted infection, could offer a new way to prevent and treat the disease, according to researchers in the Institute for Biomedical Sciences at Georgia State University.

23 Sep 2022

An unusual case of Monkeypox virus transmission by needlestick injury

In a recent study published in the U.S. Centers for Disease Control and Prevention journal Emerging Infectious Diseases, researchers described an unusual case of patient-to-healthcare worker (HCW) monkeypox virus (MPXV) transmission via a needlestick injury that occured in Brazil.

21 Sep 2022

Prophylaxis News and Research

Recent innovations in infectious disease diagnostics

Did the risk of severe COVID-19 in the immunodeficient population of the UK change following vaccination deployment?

Inhalation therapeutics against COVID-19

Amplification of venous thromboembolism risk by COVID-19 among malignancy patients

Yeast display used to generate SARS-CoV-2 RBD-specific nanobodies

Study finds the majority of post-vaccination monkeypox infections occur within 2 weeks of receiving the first dose of MVA-BN

Preventive malaria treatment is a cost-effective strategy for saving young lives

French study reports growing evidence of sexual activity-linked transmission of monkeypox

What is the efficacy of curcumin as a photosensitizer, prophylactic and therapeutic agent against SARS-CoV-2?

Designing a new treatment to treat migraine effectively

How smallpox and monkeypox viruses affect the nervous system

Generating a mutation in key molecules could offer new way to prevent and treat gonorrhea

An unusual case of Monkeypox virus transmission by needlestick injury

Virology of the human monkeypox virus

Researchers secure $4.2 million NIH grant for improving PrEP access and use in the Bronx

Synthetic mucin gels against HIV-1 and HSV-2 transmission

Study suggests healthcare personnel have a low risk of developing monkeypox when exposed to infected patients

Mucus-based prophylactic gel protects against HIV and herpes transmission

Court ruling may spur competitive health plans to bring back copays for preventive services

The kinetics of T cell response, the inflammatory profile, and the pox-specific T cell induction in monkeypox infection

One Health, One Mission: The World Organisation for Animal Health on the AMR Frontline

Uniting Against Resistance: The World Health Organization for World Antimicrobial Awareness Week 2023

Tackling Antimicrobial Resistance: A Conversation with Dr. Beverley Isherwood

Latest News